04 Oct Exact Sciences test gets boost
Exact Sciences Corp., a Madison maker of molecular diagnostic tests, said its flagship test for colon cancer has been added to a data set that is widely used to measure the quality of health plans....
Blog Large Image
New summer menus available from 12th Sept.30 Sep CDI creates company to develop drugs to fight retinal diseases
Cellular Dynamics International, Madison, has created a company, Opsis Therapeutics, to develop treatments that could restore vision to patients with diseases of the retina....
30 Sep UW System ranks #13 in world for innovation
Reuters ranks the University of Wisconsin System 13th on its list of the "The World's Most Innovative Universities"....
29 Sep Arrowhead Pharmaceuticals inks drug development deal with Amgen worth up to $673 million
Amgen, one of the world's leading biotechnology companies, is teaming with Arrowhead Pharmaceuticals to bring two drugs to market to treat cardiovascular disease in a deal worth more than $50 million to start with the potential for another $600 million or more in the future....
20 Sep Illumina, secret giant of DNA sequencing, is bringing its tech to the masses
With spin-off investments Grail and Helix, and a new software-savvy CEO, Illumina is poised to make DNA an even bigger part of your life....
16 Sep Governor Walker joins Bunker Labs in announcing The Muster-Madison
Governor Scott Walker joined Bunker Labs Wisconsin, Inc. to announce the launch of The Muster-Madison, a daylong event at the Wisconsin State Capitol that highlights interaction that will inspire, educate, and connect military veteran entrepreneurs to the startup community, business leaders, and each other....
15 Sep Madworks Accelerator accepting applications for Fall 2016 program
The Madworks Seed Accelerator is now seeking startups to participate in its Fall 2016 program. Participants receive $5,000 for completing the 10-week session....
14 Sep UW-Madison ranks high for entrepreneurs
The University of Wisconsin-Madison ranked 14th among all universities in the world in a count of how many venture capital-backed entrepreneurs it has spawned, according to a report by Pitchbook Data....
07 Sep Arrowhead kicks off Phase 2 study of AAT drug to treat liver disease
Arrowhead Pharmaceuticals has initiated a Phase 2 clinical trial for its drug candidate aimed at treating rare liver diseases associated with alpha-1 antitrypsin (AAT) deficiency....
06 Sep CDI forms two business units in Madison
Cellular Dynamics International (CDI) has changed its structure, dividing into two separate business units: Therapeutics, to develop stem cell-based drugs, and Life Science, focusing on research products....
06 Sep M.S. in Biotechnology students arrive from near and far
The Master of Science in Biotechnology program welcomed its 15th cohort of working professionals during its annual new student orientation this August....
01 Sep Stratatech acquisition becomes final; jobs will stay in Madison
Stratatech Corp., whose human skin tissue products are used to heal severe burns, is now part of the UK's Mallinckrodt Pharmaceuticals but will stay in Madison and keep all of its 55 jobs....